Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Engineered retroviral virus-like particles for receptor targeting

I. Voráčková, P. Ulbrich, WE. Diehl, T. Ruml,

. 2014 ; 159 (4) : 677-88.

Jazyk angličtina Země Rakousko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074590
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do 2017-12-31
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2002-01-01 do 2017-12-31
Public Health Database (ProQuest) od 2002-01-01 do 2017-12-31

Retroviral gag proteins, as well as fragments minimally containing the capsid (CA) and nucleocapsid (NC) subunits of Gag, are able to spontaneously assemble into virus-like particles (VLPs). This occurs in mammalian and bacterial cells as well as in in vitro systems. In every circumstance, nucleic acids are incorporated into the forming particles. Here, we took advantage of an in vitro system for the generation of non-enveloped Mason-Pfizer monkey virus (M-PMV) VLPs derived from a self-assembling CA-NC subunit of Gag. These VLPs were modified through N-terminal extension of CA-NC with short oligopeptides that, after the assembly process, were exposed on the surface of VLPs. The employed N-terminal modifications allowed specific interaction with target cells expressing prostate-specific membrane antigen. Using this system, we were able to incorporate selected siRNA into forming VLPs and deliver it into the cytosol of target cells. In comparison with other viral vectors designed for targeted transgene delivery, this M-PMV VLP system represents the lowest risk of generating virus-associated pathology, as the VLPs do not contain any viral coding sequences and are formed in a cell-free system.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074590
003      
CZ-PrNML
005      
20141007103941.0
007      
ta
008      
141006s2014 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00705-013-1873-6 $2 doi
035    __
$a (PubMed)24132720
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Voráčková, Irena $u Department of Biochemistry and Microbiology, Institute of Chemical Technology Prague, Technicka 5, 166 28, Prague 6, Czech Republic.
245    10
$a Engineered retroviral virus-like particles for receptor targeting / $c I. Voráčková, P. Ulbrich, WE. Diehl, T. Ruml,
520    9_
$a Retroviral gag proteins, as well as fragments minimally containing the capsid (CA) and nucleocapsid (NC) subunits of Gag, are able to spontaneously assemble into virus-like particles (VLPs). This occurs in mammalian and bacterial cells as well as in in vitro systems. In every circumstance, nucleic acids are incorporated into the forming particles. Here, we took advantage of an in vitro system for the generation of non-enveloped Mason-Pfizer monkey virus (M-PMV) VLPs derived from a self-assembling CA-NC subunit of Gag. These VLPs were modified through N-terminal extension of CA-NC with short oligopeptides that, after the assembly process, were exposed on the surface of VLPs. The employed N-terminal modifications allowed specific interaction with target cells expressing prostate-specific membrane antigen. Using this system, we were able to incorporate selected siRNA into forming VLPs and deliver it into the cytosol of target cells. In comparison with other viral vectors designed for targeted transgene delivery, this M-PMV VLP system represents the lowest risk of generating virus-associated pathology, as the VLPs do not contain any viral coding sequences and are formed in a cell-free system.
650    _2
$a antigeny povrchové $x metabolismus $7 D000954
650    _2
$a buněčné linie $7 D002460
650    _2
$a glutamátkarboxypeptidasa II $x metabolismus $7 D043425
650    _2
$a lidé $7 D006801
650    _2
$a makromolekulární látky $x metabolismus $7 D046911
650    _2
$a Masonův-Pfizerův opičí virus $x genetika $7 D016093
650    _2
$a malá interferující RNA $x metabolismus $7 D034741
650    12
$a transdukce genetická $7 D014161
650    _2
$a virům podobné částice $x genetika $x metabolismus $7 D022701
650    12
$a přichycení viru $7 D053585
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ulbrich, Pavel
700    1_
$a Diehl, William E
700    1_
$a Ruml, Tomáš
773    0_
$w MED00009266 $t Archives of virology $x 1432-8798 $g Roč. 159, č. 4 (2014), s. 677-88
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24132720 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141007104418 $b ABA008
999    __
$a ok $b bmc $g 1042473 $s 873502
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 159 $c 4 $d 677-88 $i 1432-8798 $m Archives of virology $n Arch Virol $x MED00009266
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...